AshiBio
āshibio is developing novel therapies for patients with rare bone and connective tissue disorders that have the potential to slow the progression of disease.
HQ location
Boston, United States
Website
Launch date
Enterprise value
$120—180m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $30.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads